Occlutech International AB

Biosense Webster Inc. – Johnson & Johnson 's heart-rhythm device business – is already the exclusive distributor of Coherex Medical Inc. 's WaveCrest left atrial appendage occlusion system out

In the market for left atrial appendage closure (LAAC) devices, Boston Scientific Corp. 's WATCHMAN device currently enjoys a monopoly in the US as the only endocardial device on the market. Othe

Since the FDA approval of Boston Scientific Corp. 's (BSX) WATCHMAN device in March, the market for transcatheter left atrial appendage closure (LAAC) devices has reached a tipping point. After a

In Vitro Diagnostics Linkage Biosciences Inc. Linkage Biosciences gets $2.1mm in Series B funding Linkage Biosciences Inc. (developing tissue-typing molecular diagnostics) brought in $2.1mm via it